1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. ROCKWELL MEDICAL INC

Rockwell Medical Inc

XNAS: RMTI

Expensive Underperformer
Download real time

1.79 0.09 (5.29%)

65.24% Fall from 52W High

87,771 XNAS Volume

XNAS 17 Mar, 2025 1:04 PM (EDT)

Watchlist

Portfolio

Share
18S
7W
1O
2T
57.9

Market Cap

Below industry Median
-46.8

PE TTM

Negative PE TTM
-0.5

PEG TTM

PEG TTM is negative
2

Price to Book

Below industry Median
0.4

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Rockwell Medical Inc is on 21 Mar 2025 for the purpose of Rockwell Medical Inc Fourth Quarter Earnings Results for 2025 See details


Insider Trading disclosures for Rockwell Medical Inc

The latest disclosure was made by Mark Strobeck in Rockwell Medical Inc where a trade of 2,163 Common Stock done at an average price of $2.1 was reported to US exchanges on Jan. 2, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Mark Strobeck Director, President and CEO Sale of securities on an exchange or to another person at price $ 2.06 per share. 02 Jan 2025 2,163 145,038 (0%) 0% 2.1 4,445 Common Stock
Timothy Chole SVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 2.05 per share. 02 Jan 2025 1,001 54,170 (0%) 0% 2.0 2,052 Common Stock
Mark H. Ravich Director Sale of securities on an exchange or to another person at price $ 2.32 per share. 15 Nov 2024 19,991 0 (0%) 0% 2.3 46,379 Common Stock
Mark H. Ravich Director Sale of securities on an exchange or to another person at price $ 2.40 per share. 15 Nov 2024 10,000 121,429 (0%) 0% 2.4 24,000 Common Stock
Mark Strobeck Director, President and CEO Sale of securities on an exchange or to another person at price $ 3.69 per share. 01 Oct 2024 2,163 147,201 (0%) 0% 3.7 7,971 Common Stock
Timothy Chole SVP, Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 3.69 per share. 01 Oct 2024 1,001 55,171 (0%) 0% 3.7 3,689 Common Stock
John G. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 36,111 95,451 (0%) 0% 0 Common Stock
Allen R. Nissenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 36,111 92,597 (0%) 0% 0 Common Stock
Mark H. Ravich Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 36,111 108,831 (0%) 0% 0 Common Stock
Robert S. Radie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 36,111 93,525 (0%) 0% 0 Common Stock
Andrea Heslin Smiley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 36,111 92,062 (0%) 0% 0 Common Stock
Joan Lau Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 36,111 63,111 (0%) 0% 0 Common Stock
Mark Strobeck Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.40 per share. 17 Mar 2024 6,101 149,364 (0%) 0% 1.4 8,541 Common Stock
Megan Timmins EVP, CLO and Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.40 per share. 17 Mar 2024 3,137 75,378 (0%) 0% 1.4 4,392 Common Stock
Mark Strobeck Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2024 100,000 155,465 (0%) 0% 0 Common Stock
Mark Strobeck Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2024 141,560 141,560 - - Stock Option (Right to Buy)
Megan Timmins EVP, CLO and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2024 50,000 78,515 (0%) 0% 0 Common Stock
Megan Timmins EVP, CLO and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2024 70,780 70,780 - - Stock Option (Right to Buy)
Jesse Neri SVP, FINANCE Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2024 33,330 33,330 (0%) 0% 0 Common Stock
Jesse Neri SVP, FINANCE Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2024 47,190 47,190 - - Stock Option (Right to Buy)
Joan Lau Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Oct 2023 25,000 27,000 (0%) 0% 0 Common Stock
Joan Lau Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Oct 2023 25,000 25,000 - - Stock Option (Right to Buy)
John G. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2023 24,715 155,594 (0%) 0% 0 Common Stock
Allen R. Nissenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2023 24,715 124,203 (0%) 0% 0 Common Stock
Mark H. Ravich Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2023 24,715 303,319 (0%) 0% 0 Common Stock
Robert S. Radie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2023 24,715 134,404 (0%) 0% 0 Common Stock
Andrea Heslin Smiley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2023 24,715 118,316 (0%) 0% 0 Common Stock
Mark Strobeck Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 77,105 77,105 - - Stock Option (Right to Buy)
Mark Strobeck Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 55,465 55,465 (0%) 0% 0 Common Stock
Megan Timmins EVP, CLO and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 28,515 28,515 (0%) 0% 0 Common Stock
Megan Timmins EVP, CLO and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 37,210 37,210 - - Stock Option (Right to Buy)
Paul E. McGarry SVP, Finance and CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 28,515 28,515 (0%) 0% 0 Common Stock
Paul E. McGarry SVP, Finance and CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 37,210 37,210 - - Stock Option (Right to Buy)
Marc L. Hoffman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 32,990 32,990 - - Stock Option (Right to Buy)
Marc L. Hoffman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 25,665 25,665 (0%) 0% 0 Common Stock
Russell L. Skibsted See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Sep 2022 80,000 80,000 - - Stock Option (Right to Buy)
Megan Timmins SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Sep 2022 80,000 80,000 - - Stock Option (Right to Buy)
Paul E. McGarry VP, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Sep 2022 60,000 60,000 - - Stock Option (Right to Buy)
Marc L. Hoffman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Sep 2022 60,000 60,000 - - Stock Option (Right to Buy)
Mark Strobeck Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2022 400,000 400,000 - - Stock Option (Right to Buy)
John G. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 25,000 130,879 (0%) 0% 0 Common Stock
Allen R. Nissenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 25,000 99,488 (0%) 0% 0 Common Stock
Mark H. Ravich Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 25,000 278,604 (0%) 0% 0 Common Stock
Robert S. Radie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 25,000 109,689 (0%) 0% 0 Common Stock
Andrea Heslin Smiley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 25,000 93,601 (0%) 0% 0 Common Stock
John G. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 50,000 105,879 (0%) 0% 0 Common Stock
John G. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 72,857 72,857 - - Stock Option (Right to Buy)
John P. Mclaughlin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 50,000 136,974 (0%) 0% 0 Common Stock
John P. Mclaughlin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 72,857 72,857 - - Stock Option (Right to Buy)
Allen R. Nissenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 50,000 74,488 (0%) 0% 0 Common Stock
Allen R. Nissenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 72,857 72,857 - - Stock Option (Right to Buy)
Mark H. Ravich Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 72,857 72,857 - - Stock Option (Right to Buy)
Mark H. Ravich Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 50,000 253,604 (0%) 0% 0 Common Stock
Robert S. Radie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 72,857 72,857 - - Stock Option (Right to Buy)
Robert S. Radie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 50,000 84,689 (0%) 0% 0 Common Stock
Andrea Heslin Smiley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 72,857 72,857 - - Stock Option (Right to Buy)
Andrea Heslin Smiley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 50,000 68,601 (0%) 0% 0 Common Stock
Russell H. Ellison Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2021 200,000 200,000 - - Stock Option (Right to Buy)
Raymond Pratt Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2021 112,500 112,500 - - Stock Option (Right to Buy)
Paul E. McGarry Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2021 75,000 75,000 - - Stock Option (Right to Buy)
Marc L. Hoffman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2021 150,000 150,000 - - Stock Option (Right to Buy)
David S. Richmond Ten Percent Owner, See Footnotes 1 and 2 Sale of securities on an exchange or to another person at price $ 1.03 per share. 21 Dec 2020 42,450 1,433,309 (2%) 0% 1.0 43,724 Common Stock
Allen R. Nissenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2020 1,488 24,488 (0%) 0% 0 Common Stock
Andrea Heslin Smiley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2020 26,042 26,042 - - Call Option (right to buy)
Andrea Heslin Smiley Director Grant, award, or other acquisition of securities at price $ 1.12 per share. 11 Dec 2020 18,601 18,601 (0%) 0% 1.1 20,833 Common Stock
Mark H. Ravich Director Other type of transaction at price $ 1.22 per share. 07 Dec 2020 219,905 219,905 (0%) 0% 1.2 269,164 Common Stock
Mark H. Ravich Director Other type of transaction at price $ 1.22 per share. 07 Dec 2020 219,905 0 (0%) 0% 1.2 269,164 Common Stock
Russell L. Skibsted See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2020 150,000 150,000 - - Stock Option (Right to Buy)
Russell L. Skibsted See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2020 600,000 600,000 - - Stock Option (Right to Buy)
Mark H. Ravich Director Other type of transaction at price $ 1.21 per share. 03 Sep 2020 11,000 0 (0%) 0% 1.2 13,310 Common Stock
Mark H. Ravich Director Other type of transaction at price $ 1.21 per share. 03 Sep 2020 173,905 213,604 (0%) 0% 1.2 210,425 Common Stock
Mark H. Ravich Director Other type of transaction at price $ 1.22 per share. 03 Sep 2020 194,905 194,905 (0%) 0% 1.2 237,784 Common Stock
Mark H. Ravich Director Other type of transaction at price $ 1.16 per share. 03 Sep 2020 10,000 203,604 (0%) 0% 1.2 11,600 Common Stock
Mark H. Ravich Director Other type of transaction at price $ 1.16 per share. 03 Sep 2020 16,000 9,000 (0%) 0% 1.2 18,560 Common Stock
Mark H. Ravich Director Other type of transaction at price $ 1.16 per share. 03 Sep 2020 9,000 16,000 (0%) 0% 1.2 10,440 Common Stock
Mark H. Ravich Director Other type of transaction at price $ 1.22 per share. 03 Sep 2020 25,000 219,905 (0%) 0% 1.2 30,500 Common Stock
David S. Richmond Ten Percent Owner, See Footnotes 1 and 2 Sale of securities on an exchange or to another person at price $ 1.02 per share. 15 Jul 2020 100,000 61,278 (0%) 0% 1.0 102,360 Common Stock
David S. Richmond Ten Percent Owner, See Footnotes 1 and 2 Sale of securities on an exchange or to another person at price $ 1.02 per share. 15 Jul 2020 100,000 64,841 (0%) 0% 1.0 102,360 Common Stock
David S. Richmond Ten Percent Owner, See Footnotes 1 and 2 Sale of securities on an exchange or to another person at price $ 1.01 per share. 15 Jul 2020 136,021 1,475,759 (2%) 0% 1.0 137,123 Common Stock
David S. Richmond Ten Percent Owner, See Footnotes 1 and 2 Sale of securities on an exchange or to another person at price $ 1.01 per share. 15 Jul 2020 185,855 3,465,803 (5%) 0% 1.0 187,806 Common Stock
David S. Richmond Ten Percent Owner, See Footnotes 1 and 2 Sale of securities on an exchange or to another person at price $ 1.10 per share. 15 Jul 2020 43,979 1,611,780 (2%) 0% 1.1 48,377 Common Stock
David S. Richmond Ten Percent Owner, See Footnotes 1 and 2 Sale of securities on an exchange or to another person at price $ 1.11 per share. 15 Jul 2020 234,145 3,651,658 (5%) 0% 1.1 259,128 Common Stock
David S. Richmond Other, See Footnotes 1 and 2 Purchase of securities on an exchange or from another person at price $ 1.94 per share. 30 Jun 2020 650 797 (0%) 0% 1.9 1,261 Common Stock
David S. Richmond Other, See Footnotes 1 and 2 Purchase of securities on an exchange or from another person at price $ 1.92 per share. 30 Jun 2020 9,946 96,255 (0%) 0% 1.9 19,096 Common Stock
David S. Richmond Other, See Footnotes 1 and 2 Purchase of securities on an exchange or from another person at price $ 1.92 per share. 30 Jun 2020 7,526 103,781 (0%) 0% 1.9 14,450 Common Stock
David S. Richmond Other, See Footnotes 1 and 2 Purchase of securities on an exchange or from another person at price $ 1.94 per share. 30 Jun 2020 1,712 180,751 (0%) 0% 1.9 3,321 Common Stock
David S. Richmond Other, See Footnotes 1 and 2 Purchase of securities on an exchange or from another person at price $ 1.95 per share. 30 Jun 2020 3,156 183,907 (0%) 0% 1.9 6,154 Common Stock
David S. Richmond Other, See Footnotes 1 and 2 Purchase of securities on an exchange or from another person at price $ 1.94 per share. 30 Jun 2020 1,682 29,778 (0%) 0% 1.9 3,263 Common Stock
David S. Richmond Other, See Footnotes 1 and 2 Purchase of securities on an exchange or from another person at price $ 2.00 per share. 30 Jun 2020 9 29,787 (0%) 0% 2 18 Common Stock
Allen R. Nissenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 34,639 34,639 - - Stock Option (Right to Buy)
Allen R. Nissenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 23,000 23,000 (0%) 0% 0 Common Stock
Paul E. McGarry Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 100,000 100,000 - - Stock Option (Right to Buy)
John G. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2020 36,000 55,879 (0%) 0% 0 Common Stock
John G. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2020 34,024 34,024 - - Stock Option (Right to Buy)
John P. Mclaughlin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2020 51,800 86,974 (0%) 0% 0 Common Stock
John P. Mclaughlin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2020 34,024 34,024 - - Stock Option (Right to Buy)
Mark H. Ravich Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2020 30,800 387,509 (0%) 0% 0 Common Stock
Mark H. Ravich Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2020 34,024 34,024 - - Stock Option (Right to Buy)
Robert S. Radie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2020 31,000 34,689 (0%) 0% 0 Common Stock
Robert S. Radie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2020 34,024 34,024 - - Stock Option (Right to Buy)
Russell H. Ellison Director, See Remarks Purchase of securities on an exchange or from another person at price $ 2.08 per share. 14 May 2020 2,000 12,050 (0%) 0% 2.1 4,160 Common Stock
Ajay Gupta Sr. VP & Chief Scientific Off. Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.27 per share. 26 Apr 2020 1,758 574,700 (0%) 0% 2.3 3,991 Common Stock
Raymond Pratt VP of Drug Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.27 per share. 26 Apr 2020 4,612 353,358 (0%) 0% 2.3 10,469 Common Stock
Russell H. Ellison Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2020 600,000 600,000 - - Stock Option (Right to Buy)
Russell H. Ellison Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2020 600,000 600,000 - - Stock Option (Right to Buy)
Robert S. Radie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2020 3,689 3,689 (0%) 0% 0 Common Stock
Robert S. Radie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2020 6,148 6,148 - - Stock Option (Right to Buy)
John P. Mclaughlin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2020 12,615 35,174 (0%) 0% 0 Common Stock
Russell H. Ellison Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2020 16,895 16,895 - - Stock Option (Right to Buy)
Russell H. Ellison Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2020 10,050 10,050 (0%) 0% 0 Common Stock
Angus Smith Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.37 per share. 28 Nov 2019 8,181 168,486 (0%) 0% 2.4 19,389 Common Stock
Marc L. Hoffman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Nov 2019 250,000 250,000 - - Stock Option (Right to Buy)
Ajay Gupta Sr. VP & Chief Scientific Off. Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.53 per share. 07 Oct 2019 31,491 576,458 (0%) 0% 2.5 79,672 Common Stock
John P. Mclaughlin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Sep 2019 28,372 28,372 - - Stock Option (Right to Buy)
John P. Mclaughlin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Sep 2019 22,559 22,559 (0%) 0% 0 Common Stock
Stuart M. Paul Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.52 per share. 04 Sep 2019 33,742 330,056 (0%) 0% 2.5 85,030 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 2.66 per share. 31 Jul 2019 1,807 52,740 (0%) 0% 2.7 4,806 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 2.42 per share. 31 Jul 2019 97 52,837 (0%) 0% 2.4 235 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 3.07 per share. 24 Jul 2019 29 77,273 (0%) 0% 3.1 89 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 3.05 per share. 24 Jul 2019 37 77,244 (0%) 0% 3.1 113 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 3.06 per share. 24 Jul 2019 100 77,207 (0%) 0% 3.1 306 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 3.06 per share. 24 Jul 2019 62 77,107 (0%) 0% 3.1 190 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 3.05 per share. 24 Jul 2019 91 77,045 (0%) 0% 3.1 278 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 3.13 per share. 24 Jul 2019 2,579 50,933 (0%) 0% 3.1 8,072 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 2.99 per share. 19 Jul 2019 92,707 161,457 (0%) 0% 3.0 277,194 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 2.89 per share. 19 Jul 2019 68,750 68,750 (0%) 0% 2.9 198,688 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 3.05 per share. 08 Jul 2019 601 76,300 (0%) 0% 3.0 1,831 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 3.05 per share. 08 Jul 2019 603 179,039 (0%) 0% 3.0 1,837 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 3.05 per share. 08 Jul 2019 5,519 48,354 (0%) 0% 3.0 16,810 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 3.05 per share. 08 Jul 2019 1,501 74,797 (0%) 0% 3.0 4,572 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 3.05 per share. 08 Jul 2019 902 75,699 (0%) 0% 3.0 2,747 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 3.05 per share. 08 Jul 2019 654 76,954 (0%) 0% 3.0 1,992 Common Stock
Angus Smith Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 3.06 per share. 28 Jun 2019 10,000 176,667 (0%) 0% 3.1 30,600 Common Stock
Paul E. McGarry Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2019 50,000 50,000 - - Stock Option (Right to Buy)
John G. Cooper None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2019 22,461 22,461 - - Stock Option (Right to Buy)
John G. Cooper None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2019 19,879 19,879 (0%) 0% 0 Common Stock
Lisa N. Colleran None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2019 18,674 18,674 (0%) 0% 0 Common Stock
Lisa N. Colleran None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2019 22,461 22,461 - - Stock Option (Right to Buy)
Robin L. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2019 22,461 22,461 - - Stock Option (Right to Buy)
Robin L. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2019 21,566 31,366 (0%) 0% 0 Common Stock
Mark H. Ravich None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2019 19,759 356,709 (0%) 0% 0 Common Stock
Mark H. Ravich None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2019 22,461 22,461 - - Stock Option (Right to Buy)
Benjamin Wolin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2019 27,710 27,710 (0%) 0% 0 Common Stock
Benjamin Wolin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2019 22,461 22,461 - - Stock Option (Right to Buy)
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 5.65 per share. 09 May 2019 353 66,736 (0%) 0% 5.6 1,993 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 5.65 per share. 09 May 2019 328 66,383 (0%) 0% 5.6 1,852 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 5.65 per share. 09 May 2019 499 66,055 (0%) 0% 5.6 2,817 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 5.65 per share. 09 May 2019 835 65,556 (0%) 0% 5.6 4,714 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 5.65 per share. 09 May 2019 2,051 38,300 (0%) 0% 5.6 11,579 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 5.65 per share. 09 May 2019 71 42,835 (0%) 0% 5.6 401 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 5.65 per share. 09 May 2019 506 178,436 (0%) 0% 5.6 2,857 Common Stock
Ajay Gupta Sr. VP & Chief Scientific Off. Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2019 28,000 28,000 - - Stock Option (Right to Buy)
Ajay Gupta Sr. VP & Chief Scientific Off. Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2019 17,000 607,949 (0%) 0% 0 Common Stock
Raymond Pratt Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2019 70,000 70,000 - - Stock Option (Right to Buy)
Raymond Pratt Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2019 40,000 357,970 (0%) 0% 0 Common Stock
David Kull Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2019 10,000 13,270 (0%) 0% 0 Common Stock
David Kull Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2019 16,000 16,000 - - Stock Option (Right to Buy)
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 5.59 per share. 27 Mar 2019 1,030 62,762 (0%) 0% 5.6 5,754 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 5.59 per share. 27 Mar 2019 719 63,481 (0%) 0% 5.6 4,017 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 5.59 per share. 27 Mar 2019 228 42,764 (0%) 0% 5.6 1,274 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 5.59 per share. 27 Mar 2019 1,554 177,930 (0%) 0% 5.6 8,682 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 5.59 per share. 27 Mar 2019 1,321 61,732 (0%) 0% 5.6 7,380 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 5.59 per share. 27 Mar 2019 1,017 60,411 (0%) 0% 5.6 5,682 Common Stock
Stuart M. Paul Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.21 per share. 15 Mar 2019 34,327 353,798 (0%) 0% 5.2 178,844 Common Stock
Stuart M. Paul Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.97 per share. 15 Mar 2019 10,000 363,798 (0%) 0% 3.0 29,700 Common Stock
Mark H. Ravich None Other type of transaction at price $ 0.00 per share. 21 Dec 2018 22,200 336,950 (0%) 0% 0 Common Stock
Mark H. Ravich None Other type of transaction at price $ 0.00 per share. 21 Dec 2018 44,400 0 (0%) 0% 0 Common Stock
Angus Smith Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Nov 2018 166,667 166,667 (0%) 0% 0 Common Stock
Angus Smith Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Nov 2018 333,333 333,333 - - Stock Option (Right to Buy)
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Oct 2018 5,541,562 5,541,562 (10%) 10% 0 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Oct 2018 5,541,562 5,541,562 - - Warrants (right to buy)
Ajay Gupta Sr. VP & Chief Scientific Off. Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Oct 2018 100,000 590,949 (1%) 0% 0 Common Stock
David Kull Principal Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.22 per share. 20 Sep 2018 4,130 3,270 (0%) 0% 4.2 17,429 Common Stock
David Kull Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.09 per share. 20 Sep 2018 5,000 7,400 (0%) 0% 3.1 15,450 Common Stock
David Kull Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2018 5,000 0 - - Stock Option (Right to Buy)
Stuart M. Paul Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Sep 2018 388,125 388,125 - - Stock Option (Right to Buy)
Stuart M. Paul Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Sep 2018 388,125 388,125 (0%) 0% 0 Common Stock
David Kull Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Aug 2018 25,000 25,000 - - Stock Option (Right to Buy)
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 4.37 per share. 27 Jun 2018 4,067 38,490 (0%) 0% 4.4 17,787 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 4.36 per share. 27 Jun 2018 14 52,537 (0%) 0% 4.4 61 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 4.37 per share. 27 Jun 2018 143 52,680 (0%) 0% 4.4 625 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 4.37 per share. 27 Jun 2018 1,852 42,536 (0%) 0% 4.4 8,100 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 4.37 per share. 27 Jun 2018 1,864 36,249 (0%) 0% 4.4 8,152 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 4.73 per share. 27 Jun 2018 4,621 34,423 (0%) 0% 4.7 21,857 Common Stock
John G. Cooper None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2018 39,838 39,838 - - Stock Option (Right to Buy)
Lisa N. Colleran None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2018 36,281 36,281 - - Stock Option (Right to Buy)
Patrick J. Bagley None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2018 32,724 32,724 - - Stock Option (Right to Buy)
Robin L. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2018 38,985 38,985 - - Stock Option (Right to Buy)
Ronald D. Boyd None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2018 36,139 36,139 - - Stock Option (Right to Buy)
Mark H. Ravich None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2018 38,416 38,416 - - Stock Option (Right to Buy)
Benjamin Wolin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2018 52,501 52,501 - - Stock Option (Right to Buy)
Robert L. Chioini Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2017 250,000 0 - - Stock Option (Right to Buy)
Robert L. Chioini Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.60 per share. 15 Dec 2017 245,076 2,549,907 (4%) 0% 6.6 1,617,502 Common Stock
Robert L. Chioini Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.50 per share. 15 Dec 2017 250,000 2,794,983 (5%) 0% 6.5 1,625,000 Common Stock
Thomas E. Klema Vice President, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.60 per share. 15 Dec 2017 86,175 671,492 (1%) 0% 6.6 568,755 Common Stock
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.50 per share. 15 Dec 2017 87,500 757,667 (1%) 0% 6.5 568,750 Common Stock
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2017 87,500 0 - - Stock Option (Right to Buy)
Patrick J. Bagley None Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.60 per share. 15 Dec 2017 49,243 116,307 (0%) 0% 6.6 325,004 Common Stock
Patrick J. Bagley None Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.50 per share. 15 Dec 2017 50,000 165,550 (0%) 0% 6.5 325,000 Common Stock
Patrick J. Bagley None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2017 50,000 0 - - Stock Option (Right to Buy)
Ronald D. Boyd None Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.60 per share. 15 Dec 2017 24,622 42,678 (0%) 0% 6.6 162,505 Common Stock
Ronald D. Boyd None Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.50 per share. 15 Dec 2017 25,000 67,300 (0%) 0% 6.5 162,500 Common Stock
Ronald D. Boyd None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2017 25,000 0 - - Stock Option (Right to Buy)
David S. Richmond Other Sale of securities on an exchange or to another person at price $ 6.53 per share. 15 Dec 2017 36 176,376 (0%) 0% 6.5 235 Common Stock
John G. Cooper None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Sep 2017 23,000 23,000 - - Stock Appreciation Right
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 6.34 per share. 10 Aug 2017 155 41,783 (0%) 0% 6.3 983 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 6.34 per share. 10 Aug 2017 126 42,100 (0%) 0% 6.3 799 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 6.34 per share. 10 Aug 2017 106 41,974 (0%) 0% 6.3 672 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 6.34 per share. 10 Aug 2017 85 41,868 (0%) 0% 6.3 539 Common Stock
David S. Richmond Other Purchase of securities on an exchange or from another person at price $ 6.34 per share. 10 Aug 2017 133 41,628 (0%) 0% 6.3 843 Common Stock
Robert L. Chioini Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.20 per share. 21 Jun 2017 118,950 2,544,983 (4%) 0% 7.2 856,440 Common Stock
Thomas E. Klema Vice President, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.20 per share. 21 Jun 2017 53,273 670,167 (1%) 0% 7.2 383,566 Common Stock
Ajay Gupta Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.20 per share. 21 Jun 2017 69,218 490,949 (0%) 0% 7.2 498,370 Common Stock
Raymond Pratt VP of Drug Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.20 per share. 21 Jun 2017 76,230 317,970 (0%) 0% 7.2 548,856 Common Stock
Mark H. Ravich Other 19 May 2017 10,000 10,000 (0%) 0% 6 60,000 Common Stock
Mark H. Ravich Other 19 May 2017 30,000 314,750 (0%) 0% 6 180,000 Common Stock
Mark H. Ravich Other 19 May 2017 100 0 - - Call Option (right to buy)
Mark H. Ravich Other 19 May 2017 300 0 - - Call Option (right to buy)
Robert L. Chioini Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2017 45,000 2,663,933 (5%) 0% 0 Common Stock
Robert L. Chioini Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2017 200,000 2,618,933 (5%) 0% 0 Common Stock
Thomas E. Klema Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2017 68,600 723,440 (1%) 0% 0 Common Stock
Patrick J. Bagley None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2017 9,800 115,550 (0%) 0% 0 Common Stock
Robin L. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2017 9,800 9,800 (0%) 0% 0 Common Stock
Ronald D. Boyd None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2017 9,800 42,300 (0%) 0% 0 Common Stock
Ajay Gupta Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2017 68,500 560,167 (1%) 0% 0 Common Stock
Raymond Pratt VP of Drug Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2017 68,500 394,200 (0%) 0% 0 Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 5.99 per share. 16 Mar 2017 1,200 17,430 (0%) 0% 6.0 7,192 Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 5.97 per share. 16 Mar 2017 3,200 12,630 (0%) 0% 6.0 19,104 Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 5.99 per share. 16 Mar 2017 700 16,730 (0%) 0% 6.0 4,193 Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 5.98 per share. 16 Mar 2017 900 15,830 (0%) 0% 6.0 5,382 Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Nov 2016 1,400 38,355 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Oct 2016 1,583 39,755 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Oct 2016 950 41,338 - - Common Stock
Robin L. Smith None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Sep 2016 25,000 25,000 - - Stock Option (right to buy)
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Sep 2016 3,505 46,858 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Sep 2016 4,570 42,288 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Aug 2016 100 63,475 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Aug 2016 2,230 61,245 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Aug 2016 1,362 59,883 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Feb 2016 1,135 50,363 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Feb 2016 4,550 51,498 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Feb 2016 3,835 56,048 - - Common Stock
Kenneth L. Holt None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2016 25,000 63,575 - - Common Stock
Kenneth L. Holt None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2016 25,000 0 - - Stock Option (right to buy)
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2015 93,750 0 - - Stock Option (Right to Buy)
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2015 93,750 738,490 - - Common Stock
Thomas E. Klema Vice President, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 15 Dec 2015 61,250 677,240 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Dec 2015 75,000 2,418,933 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Dec 2015 375,000 2,493,933 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Dec 2015 375,000 0 - - Stock Option (Right to Buy)
Patrick J. Bagley None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Dec 2015 25,000 105,750 - - Common Stock
Patrick J. Bagley None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Dec 2015 25,000 0 - - Stock Option (right to buy)
Ronald D. Boyd None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Dec 2015 12,500 0 - - Stock Option (right to buy)
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 04 Dec 2015 3,000 32,500 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 04 Dec 2015 3,250 35,500 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 04 Dec 2015 6,250 38,750 - - Common Stock
Ronald D. Boyd None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Dec 2015 12,500 45,000 - - Common Stock
Kenneth L. Holt None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Nov 2015 25,000 0 - - Stock Option (right to buy)
Kenneth L. Holt None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Nov 2015 25,000 38,575 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2015 125,000 2,118,933 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2015 200,000 1,993,933 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2015 500,000 500,000 - - Stock Option (right to buy)
Robert L. Chioini Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2015 275,000 275,000 - - Stock Option (right to buy)
Thomas E. Klema Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2015 150,000 644,740 - - Common Stock
Thomas E. Klema Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2015 215,000 215,000 - - Stock Option (right to buy)
Kenneth L. Holt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2015 35,000 35,000 - - Stock Option (right to buy)
Kenneth L. Holt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2015 15,000 36,509 - - Common Stock
Ronald D. Boyd None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2015 35,000 35,000 - - Stock Option (right to buy)
Ronald D. Boyd None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2015 15,000 32,500 - - Common Stock
Patrick J. Bagley None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2015 15,000 80,750 - - Common Stock
Patrick J. Bagley None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2015 35,000 35,000 - - Stock Option (right to buy)
Ajay Gupta Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2015 215,000 215,000 - - Stock Option (right to buy)
Ajay Gupta Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2015 165,000 491,667 - - Common Stock
Raymond Pratt VP of Drug Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2015 215,000 215,000 - - Stock Option (right to buy)
Raymond Pratt VP of Drug Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2015 165,000 325,700 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Aug 2015 4,910 1,793,933 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Aug 2015 1,890 1,789,023 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Aug 2015 300 1,787,133 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Aug 2015 2,900 1,786,833 - - Common Stock
Ajay Gupta Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 13 Aug 2015 15,000 331,667 - - Common Stock
Ajay Gupta Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 13 Aug 2015 10,000 321,667 - - Common Stock
Ajay Gupta Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Aug 2015 3,800 325,467 - - Common Stock
Ajay Gupta Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Aug 2015 1,200 326,667 - - Common Stock
Raymond Pratt VP of Drug Development Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Aug 2015 88 160,700 - - Common Stock
Raymond Pratt VP of Drug Development Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Aug 2015 4,912 160,612 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 01 May 2015 73,200 1,783,933 - - Common Stock
Thomas E. Klema Vice President, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 01 May 2015 27,440 494,740 - - Common Stock
Ajay Gupta Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 01 May 2015 15,048 346,667 - - Common Stock
Raymond Pratt VP of Drug Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 01 May 2015 34,650 155,700 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 Mar 2015 46,200 1,857,133 - - Common Stock
Thomas E. Klema Vice President, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 Mar 2015 27,440 522,180 - - Common Stock
Ajay Gupta Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 Mar 2015 31,500 361,715 - - Common Stock
Raymond Pratt VP of Drug Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 Mar 2015 34,650 190,350 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Dec 2014 335,000 2,163,333 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Dec 2014 335,000 0 - - Stock Option (right to buy)
Robert L. Chioini Director, Chairman, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 Dec 2014 260,000 1,903,333 - - Common Stock
Ronald D. Boyd None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Dec 2014 12,500 12,500 - - Common Stock
Ronald D. Boyd None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Dec 2014 12,500 0 - - Stock Option (right to buy)
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Dec 2014 57,500 607,120 - - Common Stock
Thomas E. Klema Vice President, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 17 Dec 2014 57,500 549,620 - - Common Stock
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Dec 2014 57,500 0 - - Stock Option (right to buy)
Robert L. Chioini Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2014 250,000 250,000 - - Stock Option (right to buy)
Robert L. Chioini Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2014 250,000 250,000 - - Stock Option (right to buy)
Robert L. Chioini Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2014 200,000 1,828,333 - - Common Stock
Thomas E. Klema Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2014 120,000 120,000 - - Stock Option (right to buy)
Thomas E. Klema Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2014 70,000 549,620 - - Common Stock
Kenneth L. Holt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2014 35,000 35,000 - - Stock Option (right to buy)
Ronald D. Boyd None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2014 35,000 35,000 - - Stock Option (right to buy)
Patrick J. Bagley None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2014 35,000 35,000 - - Stock Option (right to buy)
Ajay Gupta Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2014 13,000 187,000 - - Stock Option (right to buy)
Ajay Gupta Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2014 75,000 380,215 - - Common Stock
Ajay Gupta Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2014 50,000 50,000 - - Stock Option (right to buy)
Ajay Gupta Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2014 13,000 393,215 - - Common Stock
Raymond Pratt VP of Drug Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2014 75,000 225,000 - - Common Stock
Raymond Pratt VP of Drug Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2014 50,000 50,000 - - Stock Option (right to buy)
Robert L. Chioini Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2014 100,000 1,628,333 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2014 250,000 250,000 - - Stock Option (right to buy)
Thomas E. Klema Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2014 120,000 120,000 - - Stock Option (right to buy)
Thomas E. Klema Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2014 70,000 479,620 - - Common Stock
Kenneth L. Holt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2014 35,000 35,000 - - Stock Option (right to buy)
Ronald D. Boyd None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2014 35,000 35,000 - - Stock Option (right to buy)
Patrick J. Bagley None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2014 35,000 35,000 - - Stock Option (right to buy)
Ajay Gupta Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2014 75,000 305,215 - - Common Stock
Ajay Gupta Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2014 150,000 150,000 - - Stock Option (right to buy)
Raymond Pratt VP of Drug Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2014 75,000 150,000 - - Common Stock
Raymond Pratt VP of Drug Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2014 150,000 150,000 - - Stock Option (right to buy)
Ronald D. Boyd None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jan 2014 5,000 0 - - Stock Option (right to buy)
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jan 2014 105,000 1,528,333 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jan 2014 105,000 0 - - Stock Option (right to buy)
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jan 2014 30,000 0 - - Stock Option (right to buy)
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jan 2014 30,000 409,620 - - Common Stock
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Dec 2013 12,500 0 - - Stock Option (right to buy)
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Dec 2013 12,500 626,740 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Dec 2013 6,250 6,250 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Dec 2013 6,250 0 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Sep 2013 25,000 0 - - Stock Option (right to buy)
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Sep 2013 25,000 1,423,333 - - Common Stock
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Sep 2013 25,000 0 - - Stock Option (right to buy)
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Sep 2013 25,000 614,240 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Sep 2013 600 24,400 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Sep 2013 200 24,200 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Sep 2013 1,500 22,700 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Sep 2013 1,200 21,500 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Sep 2013 2,300 19,200 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Sep 2013 100 19,100 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Sep 2013 900 18,200 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Sep 2013 5,700 12,500 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Jul 2013 1,325 20,184 - - common stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Jul 2013 510 19,674 - - common stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Jul 2013 2,192 17,482 - - common stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Jul 2013 1,430 16,052 - - common stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Jul 2013 2,007 14,045 - - common stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Jul 2013 470 13,575 - - common stock
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jun 2013 300,000 0 - - Employee stock option (right to buy)
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jun 2013 300,000 1,456,333 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 18 Jun 2013 58,000 1,398,333 - - Common Stock
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jun 2013 150,000 0 - - Employee stock option (right to buy)
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jun 2013 150,000 655,138 - - Common Stock
Thomas E. Klema Vice President, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 18 Jun 2013 65,898 589,240 - - Common Stock
Ronald D. Boyd None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Jun 2013 12,500 0 - - director stock option (right to buy)
Ronald D. Boyd None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Jun 2013 12,500 12,500 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2013 100,000 1,156,333 - - Common Stock
Thomas E. Klema Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2013 60,000 505,138 - - Common Stock
Ajay Gupta Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2013 75,000 230,215 - - Common Stock
Raymond Pratt VP of Drug Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2013 75,000 75,000 - - Common Stock
Ronald D. Boyd None Other type of transaction at price $ 0.00 per share. 13 Jun 2013 8,334 16,666 - - Stock option (right to buy)
Ronald D. Boyd None Other type of transaction at price $ 0.00 per share. 13 Jun 2013 8,333 16,667 - - Stock option (right to buy)
Ronald D. Boyd None Other type of transaction at price $ 0.00 per share. 13 Jun 2013 8,333 41,667 - - Stock option (right to buy)
Kenneth L. Holt None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2013 25,000 0 - - Stock option (right to buy)
Kenneth L. Holt None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2013 10,000 0 - - Stock option (right to buy)
Kenneth L. Holt None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2013 25,000 32,900 - - Common Stock
Kenneth L. Holt None Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 08 Feb 2013 13,986 18,914 - - Common Stock
Kenneth L. Holt None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2013 10,000 28,914 - - Common Stock
Kenneth L. Holt None Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 08 Feb 2013 7,405 21,509 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2013 250,000 250,000 - - Stock Option (right to buy)
Thomas E. Klema Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2013 100,000 100,000 - - Stock Option (right to buy)
Kenneth L. Holt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2013 25,000 25,000 - - Stock Option (right to buy)
Ronald D. Boyd None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2013 25,000 25,000 - - Stock Option (right to buy)
Patrick J. Bagley None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2013 25,000 25,000 - - Stock Option (right to buy)
Ajay Gupta Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2013 150,000 150,000 - - Stock Option (right to buy)
Raymond Pratt VP of Drug Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2013 150,000 150,000 - - Stock Option (right to buy)
David A. Hagelstein Ten Percent Owner Other type of transaction at price $ 0.00 per share. 28 Jan 2013 862,502 0 - - Common Stock Warrant
David A. Hagelstein Ten Percent Owner Other type of transaction at price $ 0.00 per share. 28 Jan 2013 862,502 862,502 - - Common Stock Warrant
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 07 Dec 2012 77,000 0 - - Stock option (right to buy)
David A. Hagelstein Ten Percent Owner Other type of transaction at price $ 0.00 per share. 26 Nov 2012 862,502 0 - - Common Stock Warrant
David A. Hagelstein Ten Percent Owner Other type of transaction at price $ 0.00 per share. 26 Nov 2012 862,502 862,502 - - Common Stock Warrant
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Nov 2012 68,000 0 - - Stock option (right to buy)
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Nov 2012 68,000 452,262 - - Common Stock
Thomas E. Klema Vice President, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 16 Nov 2012 7,124 445,138 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Nov 2012 2,400 8,250 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Nov 2012 350 7,900 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 08 Nov 2012 600 11,599 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 08 Nov 2012 299 11,300 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 08 Nov 2012 650 10,650 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 27 Sep 2012 30,000 77,000 - - Stock option (right to buy)
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Aug 2012 3,500 1,357,200 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Aug 2012 3,500 1,360,700 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jun 2012 1,100 1,349,800 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jun 2012 200 1,350,000 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jun 2012 100 1,350,100 - - Commom Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jun 2012 3,600 1,353,700 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2012 100,000 1,056,333 - - Common Stock
Thomas E. Klema Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2012 60,000 384,262 - - Common Stock
Ajay Gupta Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2012 75,000 155,215 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2012 25,000 25,000 - - Stock option (right to buy)
Thomas E. Klema Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2012 25,000 25,000 - - Stock option (right to buy)
Ajay Gupta Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2012 25,000 25,000 - - Stock option (right to buy)
Raymond Pratt VP of Drug Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2012 150,000 150,000 - - Stock option (right to buy)
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 05 Jan 2012 36,000 107,000 - - Stock option (right to buy)
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 225,000 225,000 - - Stock option (right to buy)
Thomas E. Klema Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 75,000 75,000 - - Stock option (right to buy)
Kenneth L. Holt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 25,000 25,000 - - Stock option (right to buy)
Ronald D. Boyd None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 25,000 25,000 - - Stock option (right to buy)
Patrick J. Bagley None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 25,000 25,000 - - Stock option (right to buy)
Ajay Gupta Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2012 125,000 125,000 - - Stock option (right to buy)
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 Nov 2011 70,834 862,502 - - Common Stock Warrant
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Sep 2011 801 12,199 - - Common Stock
Annamaria T. Kausz VP of Drug Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Sep 2011 100,000 100,000 - - employee stock option (right to buy)
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Sep 2011 100,000 332,526 - - Common Stock
Thomas E. Klema Vice President, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 22 Sep 2011 8,264 324,262 - - Common Stock
Thomas E. Klema Vice President, CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Sep 2011 100,000 0 - - employee stock option (right to buy)
Kenneth L. Holt None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Sep 2011 25,000 38,000 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Sep 2011 6,481 31,519 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Sep 2011 5,000 26,519 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Sep 2011 3,549 22,970 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Sep 2011 4,014 18,956 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Sep 2011 5,000 13,956 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Sep 2011 956 13,000 - - Common Stock
Kenneth L. Holt None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Sep 2011 25,000 0 - - stock option (right to buy)
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Sep 2011 125,000 967,216 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 09 Sep 2011 10,883 956,333 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Sep 2011 125,000 0 - - employee stock option (right to buy)
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Jul 2011 1,000 1,339,700 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Jul 2011 1,000 1,340,700 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Jul 2011 2,000 1,342,700 - - Common Stock
David A. Hagelstein Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 04 May 2011 10,400 1,338,700 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 May 2011 25,000 791,668 - - Common Stock Warrant
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Apr 2011 1,000 1,347,100 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Apr 2011 1,000 1,348,100 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Apr 2011 1,000 1,349,100 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 06 Apr 2011 20,000 842,216 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Mar 2011 4,000 0 - - common stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Mar 2011 5,000 9,000 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Mar 2011 3,000 6,000 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Mar 2011 2,000 4,000 - - Common Stock
Ronald D. Boyd None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2011 20,000 0 - - director stock option (right to buy)
Ronald D. Boyd None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2011 20,000 20,000 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Mar 2011 400 19,600 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Mar 2011 600 19,000 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Mar 2011 200 18,800 - - Common Stock
Ronald D. Boyd None Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Mar 2011 4,800 14,000 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Mar 2011 53,668 766,668 - - Common Stock Warrant
David A. Hagelstein Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Mar 2011 18,195 1,346,100 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Feb 2011 95 1,814,847 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2011 250,000 250,000 - - stock option (right to buy)
Thomas E. Klema Vice President, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2011 100,000 100,000 - - stock option (right to buy)
Kenneth L. Holt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2011 50,000 50,000 - - stock option (right to buy)
Ronald D. Boyd None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2011 50,000 50,000 - - stock option (right to buy)
Patrick J. Bagley None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2011 50,000 50,000 - - stock option (right to buy)
Ajay Gupta Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2011 150,000 150,000 - - stock option (right to buy)
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Dec 2010 626 448,678 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Dec 2010 500 449,178 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Dec 2010 200 449,378 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Dec 2010 174 449,552 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Dec 2010 1,000 450,552 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Dec 2010 9,500 862,216 - - Common Stock
Thomas E. Klema Vice President, CFO Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Dec 2010 11,000 236,526 - - Common Stock
Thomas E. Klema Vice President, CFO Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Dec 2010 4,000 232,526 - - Common Stock
David A. Hagelstein Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 23 Nov 2010 71,000 1,364,200 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Nov 2010 313,000 713,000 - - Common Stock Warrant
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 18 Nov 2010 3,200 1,882,252 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 18 Nov 2010 1,000 1,883,252 - - Common Stock
Robert L. Chioini Director, Chairman, President and CEO, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 12 Nov 2010 50,000 125,000 - - Stock option (right to buy)
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Oct 2010 400,000 400,000 - - Common Stock Warrant
David A. Hagelstein Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 18 Oct 2010 5,000 1,431,000 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 Sep 2010 2,000 1,404,848 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 Sep 2010 1,500 1,406,348 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 Sep 2010 14,152 1,420,500 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 Sep 2010 200 1,420,700 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 Sep 2010 200 1,420,900 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 Sep 2010 200 1,421,100 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 Sep 2010 400 1,421,500 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 Sep 2010 1,000 1,522,500 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 Sep 2010 1,000 1,423,800 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 Sep 2010 1,300 1,424,800 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 Sep 2010 1,200 1,426,000 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 Sep 2010 3,500 1,854,400 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 Sep 2010 14,152 1,868,552 - - Common Stock
David A. Hagelstein Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 Sep 2010 5,500 1,874,052 - - Common Stock
David A. Hagelstein Ten Percent Owner Other type of transaction at price $ 0.00 per share. 09 Sep 2010 17,848 1,402,848 - - Common Stock
David A. Hagelstein Ten Percent Owner Other type of transaction at price $ 0.00 per share. 09 Sep 2010 17,848 448,052 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Sep 2010 4,900 13,000 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Sep 2010 1,100 20,900 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Sep 2010 2,900 18,000 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Sep 2010 100 17,900 - - Common Stock
Kenneth L. Holt None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Sep 2010 15,000 28,000 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Sep 2010 5,000 23,000 - - Common Stock
Kenneth L. Holt None Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Sep 2010 1,000 22,000 - - Common Stock
Kenneth L. Holt None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Sep 2010 15,000 0 - - Stock Option (right to buy)
Kenneth L. Holt None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Aug 2010 5,000 15,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters